背景:获得服务仍然是帮助南非口吃社区中最弱势群体的最大障碍。这种新颖的口吃疗法,利用眼睛和舌头运动之间的无意识联系,可以提供一种新的治疗方法,易于在线沟通和交付。
目的:本研究对该干预措施的可行性进行了客观和主观评估。评估工具根据综合治疗方法从整体上解决口吃的所有组成部分:核心行为,次要行为,预期和反应。
方法:收到伦理批准后,这种单主题病例设计招募了一名患有发育性口吃(DS)的成年(21岁)男性。参与者给予知情同意,并完成了四项计划评估:基线,经过5周的训练,干预后3个月和完成后24个月。该研究使用客观评估工具:口吃严重程度工具4(SSI-4);主观评估工具:SSI-4临床使用自我报告工具(CUSR);说话者口吃经历的总体评估(OASES-A);口吃中的先兆意识(PAiS)和自我报告口吃严重程度*(SRSS)(*最终评估)。
结果:参与者的分数在所有评估指标中都有所提高,这可能反映了整体的改进。该与会者报告说,该工具非常有用。没有负面后果。
结论:本病例报告表明,这种创新的治疗方法可能是可行的。没有不良反应,而治疗只会使参与者受益。结果证明了一项试点随机可行性临床试验的设计。贡献:结果表明,这是口吃治疗的必要突破,因为说明书可以很容易地翻译成任何语言。它也可以远程交付,减少无障碍障碍。
BACKGROUND: Access to services remains the biggest barrier to helping the most vulnerable in the South African Stuttering Community. This novel stuttering therapy, harnessing an unconscious link between eye and tongue movement, may provide a new therapeutic approach, easily communicated and deliverable online.
OBJECTIVE: This study provides both objective and subjective assessments of the feasibility of this intervention. Assessment tools holistically address all components of stuttering in line with comprehensive treatment approaches: core behaviours, secondary behaviours, anticipation and reactions.
METHODS: On receipt of ethical approval, this single-subject
case design recruited one adult (21-year-old) male with a developmental stutter (DS). The participant gave informed consent and completed four scheduled assessments: baseline, after 5-week training, 3 months post-intervention and 24 months post-completion. The study used objective assessment tools: Stuttering Severity Instrument-4 (SSI-4); Subjective-assessment tools: SSI-4 clinical use self-report tool (CUSR); Overall Assessment of Speaker\'s Experience of Stuttering (OASES-A); Premonitory Awareness in Stuttering (PAiS) and Self-Report Stuttering Severity* (SRSS) (*final assessment).
RESULTS: The participant\'s scores improved across all assessment measures, which may reflect a holistic improvement. The participant reported that the tool was very useful. There were no negative consequences.
CONCLUSIONS: This
case report indicates that this innovative treatment may be feasible. No adverse effects were experienced, and the treatment only benefited the participant. The results justify the design of a pilot randomised feasibility clinical trial.Contribution: The results indicate that this is a needed breakthrough in stuttering therapy as the instructions can be easily translated into any language. It can also be delivered remotely reducing accessibility barriers.